User-centred clinical decision support to implement emergency departmentinitiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomised EMBED trial

被引:26
作者
Melnick, Edward R. [1 ]
Jeffery, Molly Moore [2 ]
Dziura, James D. [1 ]
Mao, Jodi A. [3 ]
Hess, Erik P. [4 ]
Platts-Mills, Timothy F. [5 ]
Solad, Yauheni [6 ]
Paek, Hyung [6 ]
Martel, Shara [1 ]
Patel, Mehul D. [7 ]
Bankowski, Laura [1 ]
Lu, Charles [8 ]
Brandt, Cynthia [8 ]
D'Onofrio, Gail [1 ]
机构
[1] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA
[2] Mayo Clin, Dept Emergency Med, Rochester, MN USA
[3] Eastern Virginia Med Sch, Emergency Med, Norfolk, VA 23501 USA
[4] Univ Alabama Birmingham, Sch Med, Dept Emergency Med, Birmingham, AL USA
[5] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27515 USA
[6] Yale New Haven Hlth, Informat Technol Serv, New Haven, CT USA
[7] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27515 USA
[8] Yale Univ, Sch Med, Yale Ctr Med Informat, New Haven, CT USA
来源
BMJ OPEN | 2019年 / 9卷 / 05期
关键词
UNITED-STATES; OVERDOSE DEATHS; HEALTH-CARE; DESIGN; SYSTEMS; INTERVENTIONS; PERFORMANCE; DEPENDENCE; RISK;
D O I
10.1136/bmjopen-2018-028488
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The goal of this trial is to determine whether implementation of a user-centred clinical decision support (CDS) system can increase adoption of initiation of buprenorphine (BUP) into the routine emergency care of individuals with opioid use disorder (OUD). Methods A pragmatic cluster randomised trial is planned to be carried out in 20 emergency departments (EDs) across five healthcare systems over 18 months. The intervention consists of a user-centred CDS integrated into ED clinician electronic workflow and available for guidance to: (1) determine whether patients presenting to the ED meet criteria for OUD, (2) assess withdrawal symptoms and (3) ascertain and motivate patient willingness to initiate treatment. The CDS guides the ED clinician to initiate BUP and facilitate follow-up. The primary outcome is the rate of BUP initiated in the ED. Secondary outcomes are: (1) rates of receiving a referral, (2) fidelity with the CDS and (3) rates of clinicians providing any ED-initiated BUP, referral for ongoing treatment and receiving Drug Addiction Act of 2000 training. Primary and secondary outcomes will be analysed using generalised linear mixed models, with fixed effects for intervention status (CDS vs usual care), prespecified site and patient characteristics, and random effects for study site. Ethics and dissemination The protocol has been approved by the Western Institutional Review Board. No identifiable private information will be collected from patients. A waiver of informed consent was obtained for the collection of data for clinician prescribing and other activities. As a minimal risk implementation study of established best practices, an Independent Study Monitor will be utilised in place of a Data Safety Monitoring Board. Results will be reported in ClinicalTrials.gov and published in open-access, peer-reviewed journals, presented at national meetings and shared with the clinicians at participating sites via a broadcast email notification of publications.
引用
收藏
页数:9
相关论文
共 55 条
  • [31] Tracking workload in the emergency department
    Levin, Scott
    France, Daniel J.
    Hemphill, Robin
    Jones, Ian
    Chen, Kong Y.
    Rickard, Dorsey
    Makowski, Renee
    Aronsky, Dominik
    [J]. HUMAN FACTORS, 2006, 48 (03) : 526 - 539
  • [32] An evaluation of constrained randomization for the design and analysis of group-randomized trials
    Li, Fan
    Lokhnygina, Yuliya
    Murray, David M.
    Heagerty, Patrick J.
    DeLong, Elizabeth R.
    [J]. STATISTICS IN MEDICINE, 2016, 35 (10) : 1565 - 1579
  • [33] The PRECIS-2 tool: designing trials that are fit for purpose
    Loudon, Kirsty
    Treweek, Shaun
    Sullivan, Frank
    Donnan, Peter
    Thorpe, Kevin E.
    Zwarenstein, Merrick
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [34] Mattick RP, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002207.pub3, 10.1002/14651858.CD002207.pub4]
  • [35] Use of altered informed consent in pragmatic clinical research
    McKinney, Ross E., Jr.
    Beskow, Laura M.
    Ford, Daniel E.
    Lantos, John D.
    McCall, Jonathan
    Patrick-Lake, Bray
    Pletcher, Mark J.
    Rath, Brian
    Schmidt, Hollie
    Weinfurt, Kevin
    [J]. CLINICAL TRIALS, 2015, 12 (05) : 494 - 502
  • [36] Delphi Consensus on the Feasibility of Translating the ACEP Clinical Policies Into Computerized Clinical Decision Support
    Melnick, Edward R.
    Nielson, Jeffrey A.
    Finnell, John T.
    Bullard, Michael J.
    Cantrill, Stephen V.
    Cochrane, Dennis G.
    Halamka, John D.
    Handler, Jonathan A.
    Holroyd, Brian R.
    Kamens, Donald
    Kho, Abel
    McClay, James
    Shapiro, Jason S.
    Teich, Jonathan
    Wears, Robert L.
    Patel, Saumil J.
    Ward, Mary F.
    Richardson, Lynne D.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2010, 56 (04) : 317 - 320
  • [37] Analyzing incomplete longitudinal clinical trial data
    Molenberghs, G
    Thijs, H
    Jansen, I
    Beunckens, C
    Kenward, MG
    Mallinckrodt, C
    Carroll, RJ
    [J]. BIOSTATISTICS, 2004, 5 (03) : 445 - 464
  • [38] Design and analysis of group-randomized trials: A review of recent methodological developments
    Murray, DM
    Varnell, SP
    Blitstein, JL
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (03) : 423 - 432
  • [39] National Research Council (US) Panel on Handling Missing Data in Clinical Trials, 2010, The Prevention and Treatment of Missing Data in Clinical Trials
  • [40] A review of human factors principles for the design and implementation of medication safety alerts in clinical information systems
    Phansalkar, Shobha
    Edworthy, Judy
    Hellier, Elizabeth
    Seger, Diane L.
    Schedlbauer, Angela
    Avery, Anthony J.
    Bates, David W.
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2010, 17 (05) : 493 - 501